|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Net revenues | |
| Costs and expenses: | |
| Cost of sales | |
| General and administrative | |
| Sales and marketing | |
| Research and development | |
| Depreciation and amortization expense | |
| Performance incentive share-based compensation | |
| Total costs and expenses | |
| Operating loss | |
| Other income (loss): | |
| Other income (loss), net | |
| Change in fair value of convertible notes payable | |
| Interest expense | |
| Net loss | |
| Basic net loss per Ordinary Share (in pounds per share) | |
| Diluted net loss per Ordinary Share (in pounds per share) | |
| Weighted average ordinary shares outstanding, basic (in shares) | |
| Weighted average ordinary shares outstanding, diluted (in shares) |
Loading...
